LION Dandelion Tea provides special powers from regular flowers! A Natural Detox, Digestive Aid, Liv
Location: United States, New York
Employees: 11-50
Investors 1
| Date | Name | Website |
| - | Newlin | newlin.vc/ |
Mentions in press and media 7
| Date | Title | Description |
| 12.08.2021 | Lion Electric scores new order and $100 million credit | - |
| 12.08.2021 | Lion Electric : Secures New US$100 Million Credit Facility (Form 6-K) | Lion Electric Secures New US$100 Million Credit Facility MONTREAL, Aug. 11, 2021 /CNW Telbec/ - The Lion Electric Company (NYSE: LEV) (TSX: LEV) ('Lion' or the 'Company'), a leading manufacturer of all-electric medium and heavy-duty urban v... |
| 12.08.2021 | Lion Electric : Secures New US$100 Million Credit Facility | MONTREAL, Aug. 11, 2021 /CNW Telbec/ - The Lion Electric Company (NYSE: LEV) (TSX: LEV) ("Lion" or the "Company"), a leading manufacturer of all-electric medium and heavy-duty urban vehicles, today announced that it has ... |
| 03.08.2020 | Rich Heyman joins PMV Pharma, a p53 biotech, as it adds $70 million in Series D | Less than a year after pulling in an impressive $62 million Series C round, PMV Pharma is back at it again. The Cranbury, NJ-based biotech announced Monday an additional $70 million in Series D financing as it seeks to deve... |
| 20.05.2020 | Lion Capital Takes Minority Stake In Real Estate Startup REX For $25M | 17 Shares Email Facebook Twitter LinkedIn REX, a licensed residential real estate brokerage using AI and big data, announced today it has received a $25 million investment from Lion Capital in exchange for a minority stake in the company. S... |
| 01.07.2019 | Updated: Lonza sets sights on expansion, buying Novartis facility; IQVIA leads $14 million Series B funding round | → Lonza Pharma & Biotech is expanding, buying up a Swiss facility Novartis has been using to produce drug vials and plugging it into their global supply network for industry clients. As is often the case with these d... |
| 06.11.2013 | Lion Biotechnologies Completes $23.3 Million Private Financing | LOS ANGELES–(BUSINESS WIRE)–November 6, 2013– Lion Biotechnologies, Inc. (OTC Markets: LBIO) has completed a previously announced private financing with institutional and other accredited investors for gross proceeds of $23.3 million. After... |